Martina Costanzo
Overview
Explore the profile of Martina Costanzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cusato J, Manca A, Palermiti A, Mula J, Costanzo M, Antonucci M, et al.
Biomedicines
. 2023 May;
11(5).
PMID: 37239131
Background: COVID-19 is characterized by an uncontrolled inflammatory response with high pro-inflammatory cytokine production through the activation of intracellular pathways, such as mitogen-activated protein kinase (MAPK). Viruses are able to...
2.
Cusato J, Manca A, Palermiti A, Mula J, Costanzo M, Antonucci M, et al.
Antioxidants (Basel)
. 2023 May;
12(5).
PMID: 37237997
An uncontrolled inflammatory response during SARS-CoV-2 infection has been highlighted in several studies. This seems to be due to pro-inflammatory cytokines whose production could be regulated by vitamin D, ROS...
3.
Tonello S, DOnghia D, Apostolo D, Matino E, Costanzo M, Casciaro G, et al.
Viruses
. 2023 Mar;
15(3).
PMID: 36992339
More than three years have passed since the first case, and COVID-19 is still a health concern, with several open issues such as the lack of reliable predictors of a...
4.
Matino E, Tavella E, Rizzi M, Avanzi G, Azzolina D, Battaglia A, et al.
Nutrients
. 2023 Mar;
15(5).
PMID: 36904283
As lactoferrin is a nutritional supplement with proven antiviral and immunomodulatory abilities, it may be used to improve the clinical course of COVID-19. The clinical efficacy and safety of bovine...
5.
Rizzi M, Tonello S, Morani F, Rizzi E, Casciaro G, Matino E, et al.
Viruses
. 2022 Oct;
14(10).
PMID: 36298678
SARS-CoV-2 is the etiological agent of COVID-19, an extremely heterogenous disease that can cause severe respiratory failure and critical illness. To date, reliable biomarkers allowing for early patient stratification according...
6.
Zecca E, Rizzi M, Tonello S, Matino E, Costanzo M, Rizzi E, et al.
Viruses
. 2022 Aug;
14(8).
PMID: 36016388
Vaccines are the most effective means to prevent the potentially deadly effects of SARS-CoV-2 infection, but not all vaccinated individuals gain the same degree of protection. Patients undergoing chronic immunosuppressive...
7.
Manca A, Cosma S, Palermiti A, Costanzo M, Antonucci M, Vivo E, et al.
Nutrients
. 2022 Aug;
14(16).
PMID: 36014781
Background: Vitamin D deficiency has been associated with the severity of COVID-19. The role of vitamin D in pregnant women with COVID-19 has been poorly investigated to date. The aim...
8.
Rizzi M, Patrucco F, Trevisan M, Faolotto G, Mercandino A, Strola C, et al.
Panminerva Med
. 2022 Jun;
64(4):465-471.
PMID: 35713624
Background: SARS-CoV-2 is a single-stranded RNA virus, known to be the causative agent of COVID-19. As the resulting disease shows a very heterogeneous range of clinical manifestations, the identification of...
9.
Tonello S, Rizzi M, Matino E, Costanzo M, Casciaro G, Croce A, et al.
Dis Markers
. 2022 May;
2022:1568352.
PMID: 35531477
Reliable biomarkers allowing early patients' stratification for the risk of adverse outcomes in COVID-19 are lacking. Gas6, together with its tyrosine kinase receptors named TAM, is involved in the regulation...
10.
Rizzi M, Costanzo M, Tonello S, Matino E, Casciaro F, Croce A, et al.
Dis Markers
. 2022 Mar;
2022:3528312.
PMID: 35242241
Background: SARS-CoV-2 is responsible for COVID-19, a clinically heterogeneous disease, ranging from being completely asymptomatic to life-threating manifestations. An unmet clinical need is the identification at disease onset or during...